Records containing: Kidney Disease, Chronic
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study results posted · 2026-10-30Safety, Tolerability, and Feasibility of Empagliflozin Therapy in Dialysis-dependent ESKD
-
CLINICAL_TRIALS study record update · 2026-10-28A Multicenter, International, Randomized, Double-blind, Placebo-controlled Clinical Trial of the Aldosterone Synthase Inhibitor BI 690517 in Combination With Empagliflozin in Patients With Chronic Kidney Disease
-
CLINICAL_TRIALS study record update · 2026-10-14A Multicenter, International, Randomized, Double-blind, Placebo-controlled Clinical Trial of the Aldosterone Synthase Inhibitor BI 690517 in Combination With Empagliflozin in Patients With Chronic Kidney Disease
-
CLINICAL_TRIALS study record update · 2026-10-01A Multicenter, International, Randomized, Double-blind, Placebo-controlled Clinical Trial of the Aldosterone Synthase Inhibitor BI 690517 in Combination With Empagliflozin in Patients With Chronic Kidney Disease
-
CLINICAL_TRIALS study results posted · 2026-09-30Drug-gene-nutraceutical Interactions of Cannabidiol and Tacrolimus
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study results posted · 2026-06-23A Regulatory Non-interventional Study to Monitor the Safety and Efficacy of JARDIANCE® (Empagliflozin 10 mg) in Korean Patients With Chronic Kidney Disease (CKD)
-
CLINICAL_TRIALS study record update · 2026-04-24The Rutgers University Study of the Genetics of Kidney Disease
-
CLINICAL_TRIALS study record update · 2026-04-22A High Protein Egg White Pudding for People With Kidney Failure (HiPE KF)
-
CLINICAL_TRIALS study record update · 2026-04-15A Multicenter, International, Randomized, Double-blind, Placebo-controlled Clinical Trial of the Aldosterone Synthase Inhibitor BI 690517 in Combination With Empagliflozin in Patients With Chronic Kidney Disease
-
CLINICAL_TRIALS study record update · 2026-03-31A Pragmatic, Registry-based, International, Cluster-randomized Controlled Trial Examining the Use of TEACH-PD Training Modules for Incident PD Patients Versus Existing Practices on the Rate of PD-related Infections
-
CLINICAL_TRIALS study record update · 2026-03-24Monitoring of the Sympathetic/Vagal Balance Through Multiparametric Analysis of Heart Rate Variability (HRV) in Patients With Type 2 Diabetes Mellitus (Type 2 DM), With or Without Heart Failure and/or Chronic Kidney Disease, or Cardiomyopathy, With Heart Failure and/or Cardio-renal Syndrome, All Receiving Optimized Pharmacological Treatment, Including a Sodium-Glucose Co-transporter 2 Inhibitor (SGLT2i).
-
CLINICAL_TRIALS study record update · 2026-03-19Post Marketing Surveillance on Long Term Use of JARDIANCE® Tablets in Patients With Chronic Kidney Disease in Japan
-
CLINICAL_TRIALS study record update · 2026-03-18Exerkidney: A Tracking of Uremic Toxins, Exerkines, Genetic Aspects, Physical Fitness, Body Composition, and The Effects of Physical Training in People With Chronic Kidney Disease at Different Stages
-
CLINICAL_TRIALS study record update · 2026-02-13Drug-gene-nutraceutical Interactions of Cannabidiol and Tacrolimus
-
CLINICAL_TRIALS study record update · 2026-02-10KTRSensor Scotland Study: Investigating the Role of Biomarkers in Kidney Transplant Outcomes
-
CLINICAL_TRIALS study record update · 2026-02-06Clinical Evaluation of the Nova Max Pro Statsensor Point of Care Creatinine Measuring Device in the Clinical Outpatient and Home Setting & Assessment of the Patient Experience
-
CLINICAL_TRIALS study record update · 2026-01-30A Regulatory Non-interventional Study to Monitor the Safety and Efficacy of JARDIANCE® (Empagliflozin 10 mg) in Korean Patients With Chronic Kidney Disease (CKD)
-
CLINICAL_TRIALS study record update · 2026-01-28Ketoanalogue Supplementation for Muscle Protection in CKD 4 and 5 Patients With Moderately Low Protein Diet
-
CLINICAL_TRIALS study record update · 2026-01-12A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled Study to Assess the Efficacy, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Profile of BI 764198 Administered Orally Once Daily for 12 Weeks in Patients With Focal Segmental Glomerulosclerosis
-
CLINICAL_TRIALS study record update · 2025-12-24A Randomized Controlled Study of Mesenchymal Stem Cells in the Treatment of Chronic Kidney Diseases
-
CLINICAL_TRIALS study record update · 2025-12-17An Observational Study of Patients With Chronic Kidney Disease
-
CLINICAL_TRIALS study record update · 2025-12-15APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO)
-
CLINICAL_TRIALS study record update · 2025-12-04A Randomized Controlled Clinical Trial to Assess the Effect of Dapagliflozin on Renal and Cardiovascular Outcomes in Patients With Severe Chronic Kidney Disease
-
CLINICAL_TRIALS study record update · 2025-10-03Patient-Centered Lab Result Communication Tool for Older Adults With Elevated Hemoglobin A1c (A1c) or Chronic Kidney Disease (CKD)
-
CLINICAL_TRIALS study record update · 2025-09-11A Multicentre, Controlled, Randomised and Single-blind, Adaptive Phase IV Protocol to Evaluate Effectiveness and Cost-effectiveness of Pre-emptive Genotyping Strategy to Optimise Tacrolimus Dosage in a Pretransplant Chronic Kidney Disease Population Cohort